BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2652418)

  • 1. Clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in 40 recipient patients.
    Bretan PN; Baldwin N; Novick AC; Majors A; Easley K; Ng TC; Stowe N; Streem S; Steinmuller D; Rehm P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1266-7. PubMed ID: 2652418
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS).
    Bretan PN; Baldwin N; Novick AC; Ng TC; Majors A; Stowe N; Streem S; Steinmuller D; Go R; Meaney T
    Transplant Proc; 1988 Oct; 20(5):852-3. PubMed ID: 3055516
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of renal viability by high-field phosphorus-31 magnetic resonance spectrometry.
    Pomer S; Hull WE; Röhl L; Möhring K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1268. PubMed ID: 2652419
    [No Abstract]   [Full Text] [Related]  

  • 4. Pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy. Clinical experience in 40 recipient patients.
    Bretan PN; Baldwin N; Novick AC; Majors A; Easley K; Ng T; Stowe N; Rehm P; Streem SB; Steinmuller DR
    Transplantation; 1989 Jul; 48(1):48-53. PubMed ID: 2665235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of in situ renal transplant viability by 31P-MRS: experimental study in canines.
    Bretan PN; Vigneron DB; Hricak H; Price DC; Yen TS; Luo JA; Tanagho EA; James TL
    Am Surg; 1993 Mar; 59(3):182-7. PubMed ID: 8386489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [31-phosphorus magnetic resonance spectroscopy--a new research instrument in urology. Determination of current status and outlook for clinical use].
    Pomer S
    Urologe A; 1989 Jul; 28(4):223-30. PubMed ID: 2669305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy for evaluation of renal function.
    Weiner MW; Adam WR
    Semin Urol; 1985 Feb; 3(1):34-42. PubMed ID: 3890058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of viability in preserved kidneys with 31P NMR.
    Kunikata S; Ishii T; Nishioka T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1269-71. PubMed ID: 2652420
    [No Abstract]   [Full Text] [Related]  

  • 9. Ischemic injury of the small intestine studied by 31P-MRS.
    Sato A; Kataoka M; Kuwabara Y; Kimura M; Seo Y; Masaoka A
    J Surg Res; 1996 Mar; 61(2):373-8. PubMed ID: 8656611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance, a means for anatomically reliable imaging and noninvasive metabolic studies of kidney transplants].
    Pomer S; Hull WE; Fichtner K; Möhring K; Staehler G
    Helv Chir Acta; 1992 Oct; 59(3):465-6. PubMed ID: 1464542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of high-energy phosphates in human myocardium. A phosphorus 31-nuclear magnetic resonance study of the effect of temperature on atrial appendages.
    Deslauriers R; Keon WJ; Lareau S; Moir D; Saunders JK; Smith IC; Whitehead K; Mainwood GW
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):402-12. PubMed ID: 2770321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prerequisites and initial experience for the noninvasive routine evaluation of viability of experimental and human organ transplants by magnetic resonance spectroscopy.
    Henze E; Lietzenmayer R; Kunz R; Schnur G; Clausen M; Schoser K; Beger HG; Adam WE; Ankele J; Beck C
    Transplant Proc; 1990 Oct; 22(5):2404-8. PubMed ID: 2219413
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of renal viability for transplantation by high field 31P-NMR.
    Pomer S; Hull WE; Röhl L
    Transplant Proc; 1988 Oct; 20(5):899-901. PubMed ID: 3055528
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphorus-31 MRS of the kidney.
    Hricak H
    Invest Radiol; 1989 Dec; 24(12):993-6. PubMed ID: 2691445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy.
    Bretan PN; Vigneron DB; James TL; Williams RD; Hricak H; Juenemann KP; Yen TS; Tanagho EA
    J Urol; 1986 Apr; 135(4):866-71. PubMed ID: 3514965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical differences between Ringer's lactate and Collins' solution in hepatic preservation: detection by 31P magnetic resonance spectroscopy.
    Vine W; Thoma WJ; Ugurbil K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1338-9. PubMed ID: 2711434
    [No Abstract]   [Full Text] [Related]  

  • 17. 31P nuclear magnetic resonance study of renal allograft rejection in the rat.
    Shapiro JI; Haug CE; Shanley PF; Weil R; Chan L
    Transplantation; 1988 Jan; 45(1):17-21. PubMed ID: 3276047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 31P magnetic resonance spectroscopy of the isolated human donor liver--feasibility in routine clinical practice and preliminary findings.
    Wolf RF; Kamman RL; Mooyaart EL; Haagsma EB; Bleichrodt RP; Slooff MJ
    Transplantation; 1993 Apr; 55(4):949-51. PubMed ID: 8475572
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for prolonged hospitalization after kidney transplants.
    Matas AJ; Gillingham KJ; Elick BA; Dunn DL; Gruessner RW; Payne WD; Sutherland DE; Najarian JS
    Clin Transplant; 1997 Aug; 11(4):259-64. PubMed ID: 9267712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of clinical renal preservation by phosphorus-31 magnetic resonance spectroscopy.
    Bretan PN; Vigneron DB; Hricak H; Collins GM; Price DC; Tanagho EA; James TL
    J Urol; 1987 Jan; 137(1):146-50. PubMed ID: 3540322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.